#Chr	Start	End	Ref	Alt	Gene.refGene	Func.refGene	ExonicFunc.refGene	GeneDetail.refGene	AAChange.refGene	MAX_MAF	MAX_MAF_ReportedDatabase	GIV_Indian_HOM-VAR	GIV_CDFD_HOM-VAR	Zygosity	Depth	QUAL	FILTER	CADD_phred	MIM_disease.refGene	MIM_id.refGene	InterVar_automated	Orphanet_disorder.refGene	Orphanet_association_type.refGene	Trait_association(GWAS).refGene	HPO_id.refGene	HPO_name.refGene	CLNDN	CLNREVSTAT	CLNSIG	Tissue_specificity(Uniprot).refGene	SIFT_pred	SIFT4G_pred	Polyphen2_HDIV_pred	Polyphen2_HVAR_pred	LRT_pred	MutationTaster_pred	MutationAssessor_pred	FATHMM_pred	PROVEAN_pred	MetaSVM_pred	MetaLR_pred	MetaRNN_pred	M-CAP_pred	PrimateAI_pred	DEOGEN2_pred	BayesDel_addAF_pred	ClinPred_pred	LIST-S2_pred	Aloft_pred	fathmm-MKL_coding_pred	fathmm-XF_coding_pred	Interpro_domain	dbscSNV_ADA_SCORE	dbscSNV_RF_SCORE	Gene damage prediction (all Mendelian disease-causing genes).refGene	Gene damage prediction (Mendelian AD disease-causing genes).refGene	Gene damage prediction (Mendelian AR disease-causing genes).refGene	Expression(egenetics).refGene	Expression(GNF/Atlas).refGene	LoFtool_score.refGene	Essential_gene.refGene	Essential_gene_CRISPR.refGene	Essential_gene_CRISPR2.refGene	Essential_gene_gene-trap.refGene	Gene_indispensability_score.refGene	Gene_indispensability_pred.refGene	MGI_mouse_gene.refGene	MGI_mouse_phenotype.refGene	ZFIN_zebrafish_gene.refGene	ZFIN_zebrafish_structure.refGene	ZFIN_zebrafish_phenotype_quality.refGene	ZFIN_zebrafish_phenotype_tag.refGene	GnomAdExome_AF	GnomAdExome_AF_popmax	GnomAdExome_controls_AF_popmax	GnomAdGenome_AF	GnomAdGenomeAF_popmax	1000g2015aug_all	esp6500siv2_all	Kaviar_AF	abraom_freq	abraom_filter	GME_AF_popmax	GIV_Indian_AAF	GIV_Indian_HET	GIV_CDFD_AAF	GIV_CDFD_HET	#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO	FORMAT	LIB3									
chr3	32996691	32996691	A	G	GLB1	UTR3	.	NM_001317040:c.*354T>C;NM_001135602:c.*354T>C;NM_001079811:c.*354T>C;NM_000404:c.*354T>C	.	0.3051	GnomAdGenome_AF_fin	17.0	1.0	het	988	11828.6	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	Mucopolysaccharidosis,_MPS-IV-B|GM1_gangliosidosis	criteria_provided,_single_submitter	Benign	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.2186	0.3051	0.198283	0.0	0.0438416	0.209302	PASS	0.0	0.266	64.0	0.375	10.0	chr3	32996691	.	A	G	11828.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=1.5;AS_FS=2.437;AS_MQ=60;AS_MQRankSum=0;AS_QD=11.97;AS_ReadPosRankSum=0.4;AS_SOR=0.528;BaseQRankSum=1.55;DP=1016;ExcessHet=3.0103;FS=2.437;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.97;ReadPosRankSum=0.458;SOR=0.528	GT:AD:DP:GQ:PL	0/1:470,518:988:99:11836,0,10284
chr3	32998513	32998513	A	-	GLB1	intronic	.	.	.	0.4016	GnomAdGenome_AF_eas	NA	NA	het	411	2150.6	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.027	0.4016	0.0	0.0	0.000461	0.0		0.0					chr3	32998512	.	CA	C	2150.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=1;AS_FS=0.436;AS_MQ=58.66;AS_MQRankSum=-1.9;AS_QD=3.69;AS_ReadPosRankSum=-0.7;AS_SOR=0.659;BaseQRankSum=0.914;DP=537;ExcessHet=3.0103;FS=0.787;MLEAC=1;MLEAF=0.5;MQ=59.94;MQRankSum=-1.408;QD=6.62;ReadPosRankSum=-0.313;SOR=0.748	GT:AD:DP:GQ:PL	0/1:210,115:411:99:2158,0,4196
chr3	33001109	33001109	C	T	GLB1	intronic	.	.	.	1.0	GnomAdGenome_AF_ami	NA	NA	hom	961	28179.1	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.9198	1.0	0.911542	0.0	0.0001153	0.0		0.0					chr3	33001109	.	C	T	28179.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=1.8;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=29.32;AS_ReadPosRankSum=0.1;AS_SOR=0.223;BaseQRankSum=1.84;DP=983;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=29.32;ReadPosRankSum=0.123;SOR=0.223	GT:AD:DP:GQ:PL	1/1:1,960:961:99:28193,2862,0
chr3	33001340	33001340	C	A	GLB1	intronic	.	.	.	0.306	GnomAdGenome_AF_fin	NA	NA	het	988	11221.6	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.2127	0.306	0.209665	0.0	0.233441	0.0		0.0					chr3	33001340	.	C	A	11221.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-5.1;AS_FS=3.233;AS_MQ=60;AS_MQRankSum=0;AS_QD=11.36;AS_ReadPosRankSum=-0.9;AS_SOR=0.492;BaseQRankSum=-5.086;DP=1033;ExcessHet=3.0103;FS=3.233;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.36;ReadPosRankSum=-0.806;SOR=0.492	GT:AD:DP:GQ:PL	0/1:471,517:988:99:11229,0,10552
chr3	33011992	33011992	A	G	GLB1	intronic	.	.	.	0.3075	GnomAdGenome_AF_fin	NA	NA	het	1050	10859.6	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.2025	0.3075	0.199281	0.0	0.227486	0.0		0.0					chr3	33011992	.	A	G	10859.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.8;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=10.34;AS_ReadPosRankSum=-1.3;AS_SOR=0.701;BaseQRankSum=0.852;DP=1063;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.34;ReadPosRankSum=-1.25;SOR=0.701	GT:AD:DP:GQ:PL	0/1:536,514:1050:99:10867,0,11328
chr3	33012228	33012228	A	G	GLB1	intronic	.	.	.	0.2505	GnomAdGenome_AF_eas	NA	NA	het	787	8551.64	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0653	0.2505	0.118411	0.0	0.0870217	0.0		0.0					chr3	33012228	.	A	G	8551.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.6;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=10.88;AS_ReadPosRankSum=-1.4;AS_SOR=0.673;BaseQRankSum=0.691;DP=808;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.88;ReadPosRankSum=-1.333;SOR=0.668	GT:AD:DP:GQ:PL	0/1:395,391:787:99:8559,0,8598
chr3	33012369	33012369	C	T	GLB1	intronic	.	.	.	1.0	GnomAdGenome_AF_ami	NA	NA	hom	788	22882.1	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.9316	1.0	0.926118	0.0	0.0348087	0.0		0.0					chr3	33012369	.	C	T	22882.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=1.6;AS_FS=0;AS_MQ=60;AS_MQRankSum=-0.1;AS_QD=29.04;AS_ReadPosRankSum=-0.1;AS_SOR=0.368;BaseQRankSum=1.68;DP=837;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=-0.025;QD=29.04;ReadPosRankSum=-0.064;SOR=0.368	GT:AD:DP:GQ:PL	1/1:1,787:788:99:22896,2342,0
chr3	33012839	33012839	T	C	GLB1	intronic	.	.	.	1.0	GnomAdGenome_AF_ami	NA	NA	hom	815	22693.1	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.9324	1.0	0.927117	0.0	0.0001153	0.0		0.0					chr3	33012839	.	T	C	22693.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=-1;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=27.84;AS_ReadPosRankSum=1.6;AS_SOR=0.227;BaseQRankSum=-0.936;DP=837;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=27.84;ReadPosRankSum=1.68;SOR=0.227	GT:AD:DP:GQ:PL	1/1:1,814:815:99:22707,2431,0
chr3	33013823	33013823	G	A	GLB1	intronic	.	.	.	0.3055	GnomAdGenome_AF_fin	16.0	NA	het	781	8634.64	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	not_provided	criteria_provided,_single_submitter	Benign	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.2104	0.3055	0.207268	0.0	0.230636	0.211506	PASS	0.0	0.205	36.0			chr3	33013823	.	G	A	8634.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.4;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=11.06;AS_ReadPosRankSum=-0.9;AS_SOR=0.709;BaseQRankSum=0.399;DP=793;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.06;ReadPosRankSum=-0.9;SOR=0.709	GT:AD:DP:GQ:PL	0/1:400,381:781:99:8642,0,8967
chr3	33014229	33014229	A	G	GLB1	exonic	nonsynonymous SNV	.	GLB1:NM_001135602:exon12:c.T1168C:p.C390R,GLB1:NM_000404:exon15:c.T1561C:p.C521R,GLB1:NM_001079811:exon15:c.T1471C:p.C491R,GLB1:NM_001317040:exon16:c.T1705C:p.C569R	1.0	GnomAdExome_AF_eas	826.0	142.0	hom	638	16999.1	PASS	8.620	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	Benign	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	Infantile_GM1_gangliosidosis|GM1_gangliosidosis_type_2|GM1_gangliosidosis_type_3|Mucopolysaccharidosis,_MPS-IV-B|GM1_gangliosidosis|not_specified|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	T	T	B	B	N	P	.	D	N	T	T	T	.	T	.	T	T	T	.;.;.;	N	N	.;.;.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.9831	1.0	1.0	0.9326	1.0	0.927117	0.9326	0.941262	0.949918	PASS	1.0	0.999	2.0	1.0	0.0	chr3	33014229	.	A	G	16999.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=0.2;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=26.64;AS_ReadPosRankSum=0.4;AS_SOR=0.372;BaseQRankSum=0.238;DP=651;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=26.64;ReadPosRankSum=0.477;SOR=0.372	GT:AD:DP:GQ:PL	1/1:3,635:638:99:17013,1820,0
chr3	33015027	33015027	G	A	GLB1	intronic	.	.	.	0.2498	GnomAdGenome_AF_eas	NA	NA	het	728	8437.64	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0652	0.2498	0.117612	0.0	0.0866375	0.0		0.0					chr3	33015027	.	G	A	8437.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-2.7;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=11.59;AS_ReadPosRankSum=-0.4;AS_SOR=0.682;BaseQRankSum=-2.7;DP=745;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.59;ReadPosRankSum=-0.343;SOR=0.682	GT:AD:DP:GQ:PL	0/1:348,380:728:99:8445,0,7648
chr3	33015363	33015363	C	T	GLB1	intronic	.	.	.	0.249	GnomAdGenome_AF_eas	NA	NA	het	778	9170.64	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0651	0.249	0.117612	0.0	0.0867911	0.0		0.0					chr3	33015363	.	C	T	9170.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.6;AS_FS=0.516;AS_MQ=60;AS_MQRankSum=0;AS_QD=11.79;AS_ReadPosRankSum=-0.2;AS_SOR=0.671;BaseQRankSum=-0.538;DP=789;ExcessHet=3.0103;FS=0.516;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.79;ReadPosRankSum=-0.179;SOR=0.671	GT:AD:DP:GQ:PL	0/1:384,394:778:99:9178,0,8856
chr3	33015441	33015441	A	C	GLB1	intronic	.	.	.	0.2489	GnomAdGenome_AF_eas	NA	NA	het	744	7817.64	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0651	0.2489	0.117412	0.0	0.0866759	0.0		0.0					chr3	33015441	.	A	C	7817.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-3.4;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=10.51;AS_ReadPosRankSum=-2.2;AS_SOR=0.714;BaseQRankSum=-3.384;DP=767;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.51;ReadPosRankSum=-2.188;SOR=0.714	GT:AD:DP:GQ:PL	0/1:366,378:744:99:7825,0,8299
chr3	33015543	33015543	T	C	GLB1	intronic	.	.	.	0.2505	GnomAdGenome_AF_eas	NA	NA	het	820	9005.64	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0652	0.2505	0.117412	0.0	0.0865222	0.0		0.0					chr3	33015543	.	T	C	9005.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.4;AS_FS=0.521;AS_MQ=60;AS_MQRankSum=0;AS_QD=10.98;AS_ReadPosRankSum=0;AS_SOR=0.619;BaseQRankSum=-0.302;DP=849;ExcessHet=3.0103;FS=0.521;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.98;ReadPosRankSum=0.066;SOR=0.619	GT:AD:DP:GQ:PL	0/1:411,409:820:99:9013,0,9123
chr3	33015611	33015611	A	G	GLB1	intronic	.	.	.	0.812	GnomAdGenome_AF_eas	NA	NA	het	771	8232.64	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.3508	0.812	0.469449	0.0	0.351007	0.0		0.0					chr3	33015611	.	A	G	8232.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-2;AS_FS=2.443;AS_MQ=58.99;AS_MQRankSum=0;AS_QD=10.68;AS_ReadPosRankSum=-0.7;AS_SOR=0.605;BaseQRankSum=-1.982;DP=799;ExcessHet=3.0103;FS=2.443;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.68;ReadPosRankSum=-0.684;SOR=0.605	GT:AD:DP:GQ:PL	0/1:381,390:771:99:8240,0,8505
chr3	33016505	33016505	T	C	GLB1	intronic	.	.	.	0.3283	GnomAdGenome_AF_eas	9.0	NA	het	713	6759.64	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	not_provided	criteria_provided,_single_submitter	Benign	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0843	0.3283	0.154752	0.0	0.108614	0.067323	PASS	0.0	0.116	21.0			chr3	33016505	.	T	C	6759.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-6.5;AS_FS=1.74;AS_MQ=59.99;AS_MQRankSum=-1.1;AS_QD=9.48;AS_ReadPosRankSum=0.6;AS_SOR=0.614;BaseQRankSum=-6.424;DP=734;ExcessHet=3.0103;FS=1.74;MLEAC=1;MLEAF=0.5;MQ=59.99;MQRankSum=-1.051;QD=9.48;ReadPosRankSum=0.601;SOR=0.614	GT:AD:DP:GQ:PL	0/1:375,338:713:99:6767,0,8892
chr3	33016819	33016819	G	A	GLB1	exonic	stopgain	.	GLB1:NM_001135602:exon11:c.C976T:p.R326X,GLB1:NM_000404:exon14:c.C1369T:p.R457X,GLB1:NM_001079811:exon14:c.C1279T:p.R427X,GLB1:NM_001317040:exon15:c.C1513T:p.R505X	5.562e-05	GnomAdExome_AF_eas	NA	NA	het	817	8623.64	PASS	39	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	Pathogenic	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	Infantile_GM1_gangliosidosis|GM1_gangliosidosis_type_2|GM1_gangliosidosis_type_3|Mucopolysaccharidosis,_MPS-IV-B|GM1_gangliosidosis|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	Pathogenic	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	D	A	.	.	.	.	.	.	.	.	.	D	.	.	.;.;.;	D	N	.;.;.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	1.603e-05	5.562e-05	0.0001	6.981e-06	1.549e-05	0.0	0.0	6.5e-06	0.0		0.0					chr3	33016819	.	G	A	8623.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=3;AS_FS=0.517;AS_MQ=60;AS_MQRankSum=0;AS_QD=10.59;AS_ReadPosRankSum=-1.2;AS_SOR=0.738;BaseQRankSum=2.86;DP=848;ExcessHet=3.0103;FS=0.517;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.59;ReadPosRankSum=-1.047;SOR=0.742	GT:AD:DP:GQ:PL	0/1:420,394:817:99:8631,0,8827
chr3	33017318	33017318	C	T	GLB1	intronic	.	.	.	0.3263	GnomAdGenome_AF_eas	NA	NA	het	856	9539.64	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0801	0.3263	0.150559	0.0	0.106808	0.0		0.0					chr3	33017318	.	C	T	9539.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0;AS_FS=0.517;AS_MQ=60;AS_MQRankSum=0;AS_QD=11.14;AS_ReadPosRankSum=0.6;AS_SOR=0.725;BaseQRankSum=0.009;DP=866;ExcessHet=3.0103;FS=0.517;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.14;ReadPosRankSum=0.684;SOR=0.725	GT:AD:DP:GQ:PL	0/1:440,416:856:99:9547,0,9733
chr3	33017609	33017609	G	A	GLB1	intronic	.	.	.	0.3074	GnomAdGenome_AF_fin	NA	NA	het	822	8687.64	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.2341	0.3074	0.236621	0.0	0.238013	0.0		0.0					chr3	33017609	.	G	A	8687.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=6.9;AS_FS=2.45;AS_MQ=60;AS_MQRankSum=0;AS_QD=10.57;AS_ReadPosRankSum=-1;AS_SOR=0.529;BaseQRankSum=6.93;DP=844;ExcessHet=3.0103;FS=2.45;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.57;ReadPosRankSum=-0.91;SOR=0.529	GT:AD:DP:GQ:PL	0/1:441,381:822:99:8695,0,9435
chr3	33018017	33018017	G	C	GLB1	intronic	.	.	.	1.0	GnomAdGenome_AF_ami	NA	NA	hom	776	21501.1	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.929	1.0	0.924321	0.0	0.968534	0.0		0.0					chr3	33018017	.	G	C	21501.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=1.6;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=27.71;AS_ReadPosRankSum=1.4;AS_SOR=0.484;BaseQRankSum=1.66;DP=806;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=27.71;ReadPosRankSum=1.47;SOR=0.484	GT:AD:DP:GQ:PL	1/1:3,773:776:99:21515,2205,0
chr3	33018240	33018240	T	C	GLB1	intronic	.	.	.	0.356	GnomAdGenome_AF_fin	11.0	NA	het	387	3704.64	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	not_provided	criteria_provided,_single_submitter	Benign	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.2524	0.356	0.243211	0.0	0.239665	0.237805	PASS	0.0	0.139	23.0			chr3	33018240	.	T	C	3704.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-2.3;AS_FS=0.373;AS_MQ=59.63;AS_MQRankSum=-1.1;AS_QD=9.57;AS_ReadPosRankSum=0.5;AS_SOR=0.659;BaseQRankSum=-2.216;DP=401;ExcessHet=3.0103;FS=0.373;MLEAC=1;MLEAF=0.5;MQ=59.64;MQRankSum=-1.037;QD=9.57;ReadPosRankSum=0.567;SOR=0.659	GT:AD:DP:GQ:PGT:PID:PL:PS	0|1:204,183:387:99:0|1:33018240_T_C:3712,0,6966:33018240
chr3	33018254	33018254	C	A	GLB1	intronic	.	.	.	0.2518	GnomAdGenome_AF_eas	12.0	NA	het	343	3926.64	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	not_provided	criteria_provided,_single_submitter	Benign	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0707	0.2518	0.117812	0.0	0.0864069	0.076305	PASS	0.0	0.118	17.0			chr3	33018254	.	C	A	3926.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-5.3;AS_FS=0;AS_MQ=59.16;AS_MQRankSum=-0.1;AS_QD=11.45;AS_ReadPosRankSum=-1.2;AS_SOR=0.691;BaseQRankSum=-5.276;DP=356;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=59.01;MQRankSum=-0.014;QD=11.45;ReadPosRankSum=-1.141;SOR=0.691	GT:AD:DP:GQ:PGT:PID:PL:PS	0|1:169,174:343:99:1|0:33018240_T_C:3934,0,5961:33018240
chr3	33018286	33018298	AAAAAAAAAAAAA	-	GLB1	intronic	.	.	.	0.0198	GnomAdGenome_AF_ami	1.0	NA	het	103	1528.01	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0079	0.0198	0.0	0.0	0.0	0.0		0.0	0.009868	1.0			chr3	33018285	.	CAAAAAAAAAAAAA	C	1528.01	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-1.6;AS_FS=41.472;AS_MQ=44.72;AS_MQRankSum=3.2;AS_QD=6.02;AS_ReadPosRankSum=-0.9;AS_SOR=4.608;BaseQRankSum=-1.55;DP=366;ExcessHet=3.0103;FS=44.434;MLEAC=1;MLEAF=0.5;MQ=57.33;MQRankSum=3.01;QD=28.3;ReadPosRankSum=-0.97;SOR=3.515	GT:AD:DP:GQ:PL	0/1:18,36:103:99:1514,0,1600
chr3	33018738	33018738	G	A	GLB1	intronic	.	.	.	0.2494	GnomAdGenome_AF_eas	9.0	NA	het	1034	12555.6	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	not_provided	criteria_provided,_single_submitter	Benign	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0652	0.2494	0.117013	0.0	0.0865606	0.049167	PASS	0.0	0.168	42.0			chr3	33018738	.	G	A	12555.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=9;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=12.14;AS_ReadPosRankSum=0.1;AS_SOR=0.726;BaseQRankSum=9.07;DP=1055;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=59.99;MQRankSum=0;QD=12.14;ReadPosRankSum=0.123;SOR=0.726	GT:AD:DP:GQ:PL	0/1:495,539:1034:99:12563,0,9868
chr3	33019659	33019659	G	A	GLB1	intronic	.	.	.	1.0	GnomAdGenome_AF_ami	NA	NA	hom	986	28678.1	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.916	1.0	0.912141	0.0	0.965076	0.0		0.0					chr3	33019659	.	G	A	28678.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=29.09;AS_ReadPosRankSum=.;AS_SOR=0.751;DP=1015;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.09;SOR=0.751	GT:AD:DP:GQ:PL	1/1:0,986:986:99:28692,2953,0
chr3	33020700	33020700	G	A	GLB1	intronic	.	.	.	0.3197	GnomAdGenome_AF_eas	NA	NA	het	991	11563.6	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0797	0.3197	0.14377	0.0	0.104195	0.0		0.0					chr3	33020700	.	G	A	11563.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=4.8;AS_FS=0.517;AS_MQ=60;AS_MQRankSum=0;AS_QD=11.67;AS_ReadPosRankSum=0.4;AS_SOR=0.646;BaseQRankSum=4.85;DP=1008;ExcessHet=3.0103;FS=0.517;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.67;ReadPosRankSum=0.498;SOR=0.646	GT:AD:DP:GQ:PL	0/1:481,510:991:99:11571,0,10057
chr3	33020973	33020973	G	A	GLB1	intronic	.	.	.	0.2445	GnomAdGenome_AF_eas	NA	NA	het	865	10158.6	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0664	0.2445	0.112021	0.0	0.0844859	0.0		0.0					chr3	33020973	.	G	A	10158.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=2.2;AS_FS=2.45;AS_MQ=60;AS_MQRankSum=0;AS_QD=11.74;AS_ReadPosRankSum=0.2;AS_SOR=0.909;BaseQRankSum=2.24;DP=898;ExcessHet=3.0103;FS=2.45;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.74;ReadPosRankSum=0.227;SOR=0.909	GT:AD:DP:GQ:PL	0/1:428,437:865:99:10166,0,9575
chr3	33021096	33021096	A	-	GLB1	intronic	.	.	.	0.487819	1000g2015aug_all	NA	NA	het	409	1583.6	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.2733	0.4769	0.487819	0.0	0.0001153	0.0		0.0					chr3	33021095	.	GA	G	1583.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-1;AS_FS=2.879;AS_MQ=59.09;AS_MQRankSum=0;AS_QD=2.83;AS_ReadPosRankSum=0.2;AS_SOR=0.882;BaseQRankSum=-1.668;DP=521;ExcessHet=3.0103;FS=3.028;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=4.86;ReadPosRankSum=0.537;SOR=0.871	GT:AD:DP:GQ:PL	0/1:226,100:409:99:1591,0,4445
chr3	33021160	33021160	C	T	GLB1	intronic	.	.	.	0.3153	GnomAdGenome_AF_fin	NA	NA	het	664	8112.64	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.2098	0.3153	0.203674	0.0	0.227486	0.0		0.0					chr3	33021160	.	C	T	8112.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.6;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=12.22;AS_ReadPosRankSum=0.2;AS_SOR=0.676;BaseQRankSum=-0.6;DP=684;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.22;ReadPosRankSum=0.241;SOR=0.676	GT:AD:DP:GQ:PL	0/1:316,348:664:99:8120,0,7116
chr3	33021348	33021348	G	A	GLB1	intronic	.	.	.	0.2462	GnomAdGenome_AF_eas	4.0	NA	het	813	9420.64	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	not_provided	criteria_provided,_single_submitter	Benign	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0663	0.2462	0.11222	0.0	0.084678	0.049521	PASS	0.0	0.076	17.0			chr3	33021348	.	G	A	9420.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-1.8;AS_FS=1.101;AS_MQ=60;AS_MQRankSum=0;AS_QD=11.59;AS_ReadPosRankSum=0.7;AS_SOR=0.822;BaseQRankSum=-1.764;DP=840;ExcessHet=3.0103;FS=1.101;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.59;ReadPosRankSum=0.757;SOR=0.822	GT:AD:DP:GQ:PL	0/1:403,410:813:99:9428,0,9380
chr3	33021911	33021911	G	C	GLB1	intronic	.	.	.	0.246	GnomAdGenome_AF_eas	5.0	NA	het	895	10323.6	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	not_provided	criteria_provided,_single_submitter	Benign	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0663	0.246	0.11222	0.0	0.0846012	0.047957	PASS	0.0	0.081	13.0			chr3	33021911	.	G	C	10323.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=1.1;AS_FS=1.1;AS_MQ=60;AS_MQRankSum=0;AS_QD=11.54;AS_ReadPosRankSum=0.4;AS_SOR=0.701;BaseQRankSum=1.16;DP=923;ExcessHet=3.0103;FS=1.1;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.53;ReadPosRankSum=0.405;SOR=0.701	GT:AD:DP:GQ:PL	0/1:439,456:895:99:10331,0,9914
chr3	33022564	33022564	-	TTTTTTTTTTTTTTTT	GLB1	intronic	.	.	.	0.1246	GnomAdGenome_AF_asj	NA	NA	het	33	7631.02	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.1035	0.1246	0.0	0.0	0.0	0.0		0.0					chr3	33022564	.	A	ATTTTTTTTTTTTTTTT	7631.02	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=42.43;AS_MQRankSum=.;AS_QD=17.5;AS_ReadPosRankSum=.;AS_SOR=2.303;DP=311;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=58.59;QD=32.39;SOR=4.174	GT:AD:DP:GQ:PL	1/0:0,4:33:67:7648,836,304
chr3	33022564	33022564	-	TTTTTTTTTTTTTTTTTTT	GLB1	intronic	.	.	.	0.0609	GnomAdGenome_AF_ami	NA	NA	het	33	7631.02	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0298	0.0609	0.0	0.0	0.0	0.0		0.0					chr3	33022564	.	A	ATTTTTTTTTTTTTTTTTTT	7631.02	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=35.9;AS_MQRankSum=.;AS_QD=17.06;AS_ReadPosRankSum=.;AS_SOR=4.174;DP=311;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=58.59;QD=32.39;SOR=4.174	GT:AD:DP:GQ:PL	0/1:0,18:33:67:7648,586,67
chr3	33023057	33023057	C	A	GLB1	intronic	.	.	.	0.3064	GnomAdGenome_AF_fin	NA	NA	het	903	8866.64	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.2268	0.3064	0.227636	0.0	0.233364	0.0		0.0					chr3	33023057	.	C	A	8866.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.8;AS_FS=1.104;AS_MQ=60;AS_MQRankSum=0;AS_QD=9.82;AS_ReadPosRankSum=1.4;AS_SOR=0.575;BaseQRankSum=0.87;DP=928;ExcessHet=3.0103;FS=1.104;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=9.82;ReadPosRankSum=1.45;SOR=0.575	GT:AD:DP:GQ:PL	0/1:495,408:903:99:8874,0,11167
chr3	33023500	33023500	T	C	GLB1	intronic	.	.	.	0.2449	GnomAdGenome_AF_eas	NA	NA	het	885	10290.6	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0594	0.2449	0.105232	0.0	0.0021131	0.0		0.0					chr3	33023500	.	T	C	10290.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-1.1;AS_FS=0.519;AS_MQ=60;AS_MQRankSum=0;AS_QD=11.63;AS_ReadPosRankSum=-1;AS_SOR=0.644;BaseQRankSum=-1.016;DP=920;ExcessHet=3.0103;FS=0.519;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.63;ReadPosRankSum=-0.954;SOR=0.644	GT:AD:DP:GQ:PL	0/1:419,466:885:99:10298,0,9265
chr3	33023558	33023558	T	-	GLB1	intronic	.	.	.	0.0034	GnomAdGenome_AF_fin	NA	NA	het	769	1504.6	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0005	0.0034	0.0	0.0	0.0002305	0.0		0.0					chr3	33023557	.	CT	C	1504.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.2;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=1.32;AS_ReadPosRankSum=-1.1;AS_SOR=0.751;BaseQRankSum=-1.179;DP=894;ExcessHet=3.0103;FS=1.167;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=2.39;ReadPosRankSum=-0.354;SOR=0.829	GT:AD:DP:GQ:PL	0/1:501,128:769:99:1512,0,12755
chr3	33024556	33024556	C	T	GLB1	intronic	.	.	.	0.2442	GnomAdGenome_AF_eas	6.0	NA	het	986	11067.6	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	not_provided	criteria_provided,_single_submitter	Benign	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0712	0.2442	0.116214	0.0	0.0855233	0.032374	PASS	0.0	0.085	14.0			chr3	33024556	.	C	T	11067.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=5.9;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=11.23;AS_ReadPosRankSum=0.3;AS_SOR=0.68;BaseQRankSum=5.99;DP=1028;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.22;ReadPosRankSum=0.329;SOR=0.68	GT:AD:DP:GQ:PL	0/1:520,466:986:99:11075,0,11307
chr3	33043731	33043731	C	G	GLB1	intronic	.	.	.	0.965	GnomAdGenome_AF_ami	NA	NA	het	828	10094.6	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.8578	0.965	0.808506	0.0	0.0001153	0.0		0.0					chr3	33043731	.	C	G	10094.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=2.8;AS_FS=6.969;AS_MQ=60;AS_MQRankSum=0;AS_QD=12.19;AS_ReadPosRankSum=1;AS_SOR=0.954;BaseQRankSum=2.87;DP=844;ExcessHet=3.0103;FS=6.969;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.19;ReadPosRankSum=1.1;SOR=0.954	GT:AD:DP:GQ:PL	0/1:396,432:828:99:10102,0,8769
chr3	33043786	33043786	-	AAAT	GLB1	intronic	.	.	.	0.4587	GnomAdGenome_AF_fin	NA	NA	het	593	12095.6	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.3453	0.4587	0.0	0.0	0.0638927	0.0		0.0					chr3	33043786	.	A	AAAAT	12095.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-1.6;AS_FS=4.037;AS_MQ=60;AS_MQRankSum=0;AS_QD=20.4;AS_ReadPosRankSum=0;AS_SOR=0.504;BaseQRankSum=-1.535;DP=655;ExcessHet=3.0103;FS=4.037;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=20.4;ReadPosRankSum=0.057;SOR=0.504	GT:AD:DP:GQ:PL	0/1:280,313:593:99:12103,0,10649
chr3	33043844	33043844	-	A	GLB1	intronic	.	.	.	0.7596	GnomAdGenome_AF_ami	NA	NA	het	294	2437.02	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.573	0.7596	0.445088	0.0	0.0001153	0.0		0.0					chr3	33043844	.	G	GA	2437.02	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=1.3;AS_FS=1.556;AS_MQ=60;AS_MQRankSum=0;AS_QD=0.72;AS_ReadPosRankSum=0.6;AS_SOR=0.93;BaseQRankSum=0.567;DP=475;ExcessHet=3.0103;FS=13.455;MLEAC=1;MLEAF=0.5;MQ=59.92;MQRankSum=-0.631;QD=12.69;ReadPosRankSum=0.216;SOR=1.652	GT:AD:DP:GQ:PL	1/0:43,77:294:96:2454,262,1041
chr3	33043844	33043844	-	AA	GLB1	intronic	.	.	.	0.3169	GnomAdGenome_AF_amr	NA	NA	het	294	2437.02	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.2526	0.3169	0.0	0.0	0.0001153	0.0		0.0					chr3	33043844	.	G	GAA	2437.02	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.4;AS_FS=4.257;AS_MQ=46.37;AS_MQRankSum=0;AS_QD=1.35;AS_ReadPosRankSum=0.3;AS_SOR=1.27;BaseQRankSum=0.567;DP=475;ExcessHet=3.0103;FS=13.455;MLEAC=1;MLEAF=0.5;MQ=59.92;MQRankSum=-0.631;QD=12.69;ReadPosRankSum=0.216;SOR=1.652	GT:AD:DP:GQ:PL	0/1:43,72:294:96:2454,96,1810
chr3	33043958	33043958	T	C	GLB1	intronic	.	.	.	0.4335	GnomAdGenome_AF_amr	NA	NA	het	877	10204.6	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.3104	0.4335	0.341853	0.0	0.305402	0.0		0.0					chr3	33043958	.	T	C	10204.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=2.1;AS_FS=0.528;AS_MQ=60;AS_MQRankSum=0;AS_QD=11.66;AS_ReadPosRankSum=-1.5;AS_SOR=0.775;BaseQRankSum=2.01;DP=902;ExcessHet=3.0103;FS=0.528;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.66;ReadPosRankSum=-1.448;SOR=0.764	GT:AD:DP:GQ:PL	0/1:431,444:877:99:10212,0,9649
chr3	33044437	33044437	T	C	GLB1	intronic	.	.	.	0.2446	GnomAdGenome_AF_eas	NA	NA	het	988	11212.6	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0677	0.2446	0.108626	0.0	0.0808744	0.0		0.0					chr3	33044437	.	T	C	11212.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=1.1;AS_FS=1.1;AS_MQ=60;AS_MQRankSum=0;AS_QD=11.35;AS_ReadPosRankSum=-0.6;AS_SOR=0.795;BaseQRankSum=1.14;DP=1023;ExcessHet=3.0103;FS=1.1;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.35;ReadPosRankSum=-0.59;SOR=0.795	GT:AD:DP:GQ:PL	0/1:494,494:988:99:11220,0,11208
chr3	33044603	33044604	AT	-	GLB1	intronic	.	.	.	0.2418	GnomAdGenome_AF_eas	NA	NA	het	899	17767.6	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.068	0.2418	0.111222	0.0	0.0134086	0.0		0.0					chr3	33044602	.	CAT	C	17767.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.8;AS_FS=0;AS_MQ=59.8;AS_MQRankSum=0;AS_QD=19.76;AS_ReadPosRankSum=-1.5;AS_SOR=0.706;BaseQRankSum=0.799;DP=935;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=19.76;ReadPosRankSum=-1.408;SOR=0.706	GT:AD:DP:GQ:PL	0/1:440,459:899:99:17775,0,16866
chr3	33045026	33045026	T	-	GLB1	intronic	.	.	.	0.7843	GnomAdGenome_AF_eas	NA	NA	het	850	10631.6	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.4144	0.7843	0.498802	0.0	0.0001153	0.0		0.0					chr3	33045025	.	AT	A	10631.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-2.2;AS_FS=0.521;AS_MQ=60;AS_MQRankSum=0;AS_QD=12.52;AS_ReadPosRankSum=1;AS_SOR=0.753;BaseQRankSum=-2.116;DP=946;ExcessHet=3.0103;FS=0.521;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.52;ReadPosRankSum=1.04;SOR=0.748	GT:AD:DP:GQ:PL	0/1:415,434:850:99:10639,0,9968
chr3	33045246	33045246	T	-	GLB1	intronic	.	.	.	0.085	GnomAdGenome_AF_eas	NA	NA	het	635	4879.6	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0147	0.085	0.0	0.0	0.0006531	0.0		0.0					chr3	33045245	.	CT	C	4879.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.4;AS_FS=1.785;AS_MQ=60;AS_MQRankSum=0;AS_QD=7.98;AS_ReadPosRankSum=-0.3;AS_SOR=0.54;BaseQRankSum=1.07;DP=727;ExcessHet=3.0103;FS=1.757;MLEAC=1;MLEAF=0.5;MQ=59.97;MQRankSum=-0.992;QD=9.02;ReadPosRankSum=-0.475;SOR=0.556	GT:AD:DP:GQ:PL	0/1:316,225:635:99:4887,0,7138
chr3	33046881	33046881	A	G	GLB1	intronic	.	.	.	1.0	GnomAdGenome_AF_ami	NA	NA	hom	726	20216.1	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.9889	1.0	0.982228	0.0	0.0001153	0.0		0.0					chr3	33046881	.	A	G	20216.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=27.85;AS_ReadPosRankSum=.;AS_SOR=0.853;DP=738;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.85;SOR=0.853	GT:AD:DP:GQ:PL	1/1:0,726:726:99:20230,2168,0
chr3	33047293	33047293	C	T	GLB1	intronic	.	.	.	0.2494	GnomAdGenome_AF_eas	NA	NA	het	997	10463.6	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.053	0.2494	0.0966454	0.0	0.0730751	0.0		0.0					chr3	33047293	.	C	T	10463.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-1;AS_FS=1.101;AS_MQ=60;AS_MQRankSum=0;AS_QD=10.5;AS_ReadPosRankSum=-0.4;AS_SOR=0.715;BaseQRankSum=-0.965;DP=1018;ExcessHet=3.0103;FS=1.101;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.5;ReadPosRankSum=-0.345;SOR=0.715	GT:AD:DP:GQ:PL	0/1:516,481:997:99:10471,0,11578
chr3	33047955	33047955	A	-	GLB1	intronic	.	.	.	0.1094	GnomAdGenome_AF_afr	NA	NA	het	759	137.6	QD2	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0564	0.1094	0.0742812	0.0	0.0087214	0.0		0.0					chr3	33047954	.	GA	G	137.6	QD2	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=0.2;AS_ReadPosRankSum=2.1;AS_SOR=0.821;BaseQRankSum=-0.366;DP=891;ExcessHet=3.0103;FS=0.647;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=0.2;ReadPosRankSum=2.25;SOR=0.817	GT:AD:DP:GQ:PL	0/1:598,89:759:99:145,0,16025
chr3	33047988	33047988	A	G	GLB1	intronic	.	.	.	0.0	GnomAdExome_AF	NA	NA	het	855	9548.64	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0					chr3	33047988	.	A	G	9548.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.3;AS_FS=1.107;AS_MQ=60;AS_MQRankSum=0;AS_QD=11.17;AS_ReadPosRankSum=-0.1;AS_SOR=0.772;BaseQRankSum=0.378;DP=887;ExcessHet=3.0103;FS=1.107;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.17;ReadPosRankSum=-0.064;SOR=0.772	GT:AD:DP:GQ:PGT:PID:PL:PS	0|1:417,438:855:99:1|0:33047955_AAAAAAAAAAACCCAC_A:9556,0,9140:33047955
chr3	33051234	33051234	A	-	GLB1	intronic	.	.	.	0.0137	GnomAdGenome_AF_afr	NA	NA	het	28	56.6	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0047	0.0137	0.0	0.0	0.0	0.0		0.0					chr3	33051233	.	CA	C	56.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=1.6;AS_FS=14.523;AS_MQ=60;AS_MQRankSum=0;AS_QD=2.38;AS_ReadPosRankSum=0.7;AS_SOR=0.012;BaseQRankSum=2.6;DP=43;ExcessHet=3.0103;FS=31.491;MLEAC=1;MLEAF=0.5;MQ=59.47;MQRankSum=0;QD=2.36;ReadPosRankSum=0.899;SOR=1.389	GT:AD:DP:GQ:PL	0/1:18,6:28:64:64,0,414
chr3	33051236	33051236	A	G	GLB1	intronic	.	.	.	0.0022	GnomAdGenome_AF_fin	NA	NA	het	29	53.63	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.001	0.0022	0.0	0.0	0.0	0.0		0.0					chr3	33051236	.	A	G	53.63	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.9;AS_FS=9.51;AS_MQ=60;AS_MQRankSum=0;AS_QD=2.08;AS_ReadPosRankSum=1.9;AS_SOR=0.048;BaseQRankSum=-0.839;DP=40;ExcessHet=3.0103;FS=19.887;MLEAC=1;MLEAF=0.5;MQ=59.43;MQRankSum=0;QD=2.06;ReadPosRankSum=2.37;SOR=1.135	GT:AD:DP:GQ:PL	0/1:20,6:29:61:61,0,457
chr3	33051415	33051415	G	A	GLB1	intronic	.	.	.	0.0037	GnomAdGenome_AF_sas	NA	NA	het	105	1092.64	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	7.724e-05	0.0037	0.00199681	0.0	0.0004226	0.0		0.0					chr3	33051415	.	G	A	1092.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.8;AS_FS=1.567;AS_MQ=60;AS_MQRankSum=1.3;AS_QD=10.41;AS_ReadPosRankSum=0.7;AS_SOR=0.534;BaseQRankSum=-0.711;DP=111;ExcessHet=3.0103;FS=1.567;MLEAC=1;MLEAF=0.5;MQ=59.85;MQRankSum=1.39;QD=10.41;ReadPosRankSum=0.792;SOR=0.534	GT:AD:DP:GQ:PL	0/1:54,51:105:99:1100,0,1234
chr3	33051552	33051552	T	C	GLB1	intronic	.	.	.	0.017405	abraom_freq	NA	NA	het	59	162.64	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	not_provided	criteria_provided,_single_submitter	Likely_benign	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0105	0.0173	0.00539137	0.0	0.0123713	0.017405	PASS	0.0					chr3	33051552	.	T	C	162.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.5;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=2.76;AS_ReadPosRankSum=1.3;AS_SOR=0.578;BaseQRankSum=0.552;DP=61;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=2.76;ReadPosRankSum=1.34;SOR=0.578	GT:AD:DP:GQ:PL	0/1:47,12:59:99:170,0,1143
chr3	33051604	33051604	A	-	GLB1	intronic	.	.	.	0.3156	GnomAdGenome_AF_afr	NA	NA	het	40	255.6	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	not_provided	criteria_provided,_single_submitter	Benign	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.1134	0.3156	0.0	0.0	0.0004226	0.276758	PASS	0.0					chr3	33051603	.	CA	C	255.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.3;AS_FS=17.515;AS_MQ=60;AS_MQRankSum=0.8;AS_QD=3.2;AS_ReadPosRankSum=0.7;AS_SOR=3.238;BaseQRankSum=0.629;DP=49;ExcessHet=3.0103;FS=7.118;MLEAC=1;MLEAF=0.5;MQ=59.83;MQRankSum=1.34;QD=10.22;ReadPosRankSum=1.37;SOR=1.218	GT:AD:DP:GQ:PL	0/1:15,10:40:99:263,0,255
chr3	33051698	33051698	T	C	GLB1	intronic	.	.	.	0.9994	GnomAdGenome_AF_eas	185.0	128.0	hom	104	2870.06	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	Infantile_GM1_gangliosidosis|Mucopolysaccharidosis,_MPS-IV-B|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.7569	0.9994	0.780152	0.7444	0.170218	0.804598	PASS	0.0	0.936	23.0	0.943662	12.0	chr3	33051698	.	T	C	2870.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=27.6;AS_ReadPosRankSum=.;AS_SOR=0.946;DP=107;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.6;SOR=0.946	GT:AD:DP:GQ:PL	1/1:0,104:104:99:2884,309,0
chr3	33052136	33052136	A	C	GLB1	intronic	.	.	.	0.8987	GnomAdGenome_AF_ami	115.0	41.0	hom	84	2307.06	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	not_provided	criteria_provided,_single_submitter	Benign	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.6864	0.8987	0.608227	0.0	0.152204	0.738137	PASS	0.0	0.729	76.0	0.666667	30.0	chr3	33052136	.	A	C	2307.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=27.46;AS_ReadPosRankSum=.;AS_SOR=0.741;DP=90;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.47;SOR=0.741	GT:AD:DP:GQ:PL	1/1:0,84:84:99:2321,251,0
chr3	33052963	33052963	C	G	GLB1	intronic	.	.	.	0.2487	GnomAdGenome_AF_eas	NA	NA	het	58	436.64	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0529	0.2487	0.0974441	0.0	0.0732673	0.0		0.0					chr3	33052963	.	C	G	436.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-1.1;AS_FS=3.84;AS_MQ=60;AS_MQRankSum=0;AS_QD=7.53;AS_ReadPosRankSum=1;AS_SOR=0.686;BaseQRankSum=-1.007;DP=61;ExcessHet=3.0103;FS=3.84;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=7.53;ReadPosRankSum=1.06;SOR=0.686	GT:AD:DP:GQ:PL	0/1:38,20:58:99:444,0,948
chr3	33055461	33055462	TT	-	GLB1	intronic	.	.	.	0.0266	GnomAdGenome_AF_afr	NA	NA	het	18	239.02	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0095	0.0266	0.0	0.0	0.0005379	0.0		0.0					chr3	33055460	.	CTT	C	239.02	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=1.1;AS_FS=0;AS_MQ=60;AS_MQRankSum=1.6;AS_QD=6.09;AS_ReadPosRankSum=1.2;AS_SOR=0.941;BaseQRankSum=1.88;DP=25;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=58.65;MQRankSum=2.83;QD=13.28;ReadPosRankSum=1.33;SOR=1.329	GT:AD:DP:GQ:PL	1/0:4,7:18:59:256,59,168
chr3	33055461	33055461	T	-	GLB1	intronic	.	.	.	0.9531	GnomAdGenome_AF_ami	NA	NA	het	18	239.02	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.8888	0.9531	0.883586	0.0	0.0002305	0.0		0.0					chr3	33055460	.	CT	C	239.02	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=2.1;AS_FS=3.09;AS_MQ=60;AS_MQRankSum=1.6;AS_QD=4.45;AS_ReadPosRankSum=0.9;AS_SOR=2.584;BaseQRankSum=1.88;DP=25;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=58.65;MQRankSum=2.83;QD=13.28;ReadPosRankSum=1.33;SOR=1.329	GT:AD:DP:GQ:PL	0/1:4,7:18:59:256,77,110
chr3	33055491	33055491	C	T	GLB1	intronic	.	.	.	0.0177	GnomAdGenome_AF_nfe	NA	NA	het	24	73.64	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0113	0.0177	0.00878594	0.0	0.0129092	0.0		0.0					chr3	33055491	.	C	T	73.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=1.5;AS_FS=2.007;AS_MQ=60;AS_MQRankSum=0.8;AS_QD=3.08;AS_ReadPosRankSum=-0.5;AS_SOR=0.85;BaseQRankSum=1.5;DP=28;ExcessHet=3.0103;FS=2.007;MLEAC=1;MLEAF=0.5;MQ=58.8;MQRankSum=0.816;QD=3.07;ReadPosRankSum=-0.463;SOR=0.85	GT:AD:DP:GQ:PL	0/1:19,5:24:81:81,0,382
chr3	33055769	33055769	T	-	GLB1	intronic	.	.	.	0.0263	GnomAdGenome_AF_afr	NA	NA	het	25	37.6	QD2	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0089	0.0263	0.0	0.0	0.0001617	0.0		0.0					chr3	33055768	.	GT	G	37.6	QD2	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=1.1;AS_FS=1.935;AS_MQ=60;AS_MQRankSum=0;AS_QD=1.65;AS_ReadPosRankSum=-1.1;AS_SOR=0.895;BaseQRankSum=1.18;DP=29;ExcessHet=3.0103;FS=4.222;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=1.63;ReadPosRankSum=-0.575;SOR=1.541	GT:AD:DP:GQ:PL	0/1:18,5:25:45:45,0,474
chr3	33055953	33055953	C	T	GLB1	intronic	.	.	.	0.2445	GnomAdGenome_AF_amr	NA	NA	het	36	517.64	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.1388	0.2445	0.151158	0.0	0.163439	0.0		0.0					chr3	33055953	.	C	T	517.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.4;AS_FS=1.356;AS_MQ=59.45;AS_MQRankSum=-0.7;AS_QD=14.39;AS_ReadPosRankSum=0.6;AS_SOR=0.446;BaseQRankSum=0.462;DP=40;ExcessHet=3.0103;FS=1.356;MLEAC=1;MLEAF=0.5;MQ=59.67;MQRankSum=-0.648;QD=14.38;ReadPosRankSum=0.641;SOR=0.446	GT:AD:DP:GQ:PL	0/1:12,24:36:99:525,0,181
chr3	33056036	33056036	G	T	GLB1	intronic	.	.	.	1.0	GnomAdGenome_AF_ami	NA	NA	hom	34	957.06	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.9683	1.0	0.957468	0.0	0.0001153	0.0		0.0					chr3	33056036	.	G	T	957.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=59.55;AS_MQRankSum=.;AS_QD=28.15;AS_ReadPosRankSum=.;AS_SOR=1.085;DP=37;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=59.59;QD=28.15;SOR=1.085	GT:AD:DP:GQ:PL	1/1:0,34:34:99:971,102,0
chr3	33056419	33056419	T	-	GLB1	intronic	.	.	.	0.0204	GnomAdGenome_AF_afr	NA	NA	het	49	282.6	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0082	0.0204	0.0	0.0	0.0002305	0.0		0.0					chr3	33056418	.	CT	C	282.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.6;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=6.6;AS_ReadPosRankSum=-0.1;AS_SOR=0.778;BaseQRankSum=0.098;DP=54;ExcessHet=3.0103;FS=4.112;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=7.07;ReadPosRankSum=-0.463;SOR=1.294	GT:AD:DP:GQ:PL	0/1:27,13:49:99:290,0,601
chr3	33056563	33056563	G	A	GLB1	intronic	.	.	.	0.7341	GnomAdGenome_AF_asj	NA	NA	hom	60	1557.06	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.5316	0.7341	0.460064	0.0	0.612763	0.0		0.0					chr3	33056563	.	G	A	1557.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=25.95;AS_ReadPosRankSum=.;AS_SOR=0.831;DP=63;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=25.95;SOR=0.831	GT:AD:DP:GQ:PL	1/1:0,60:60:99:1571,177,0
chr3	33057492	33057492	C	T	GLB1	intronic	.	.	.	1.0	GnomAdGenome_AF_ami	NA	NA	hom	87	2444.06	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.9732	1.0	0.965256	0.0	0.944329	0.0		0.0					chr3	33057492	.	C	T	2444.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=28.09;AS_ReadPosRankSum=.;AS_SOR=0.763;DP=88;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.09;SOR=0.763	GT:AD:DP:GQ:PL	1/1:0,87:87:99:2458,261,0
chr3	33058011	33058011	T	C	GLB1	intronic	.	.	.	0.2716	GnomAdGenome_AF_eas	8.0	3.0	het	74	242.64	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	Infantile_GM1_gangliosidosis|Mucopolysaccharidosis,_MPS-IV-B|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0586	0.2716	0.101238	0.0	0.0153167	0.046798	PASS	0.0	0.127	44.0	0.15	21.0	chr3	33058011	.	T	C	242.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-1.1;AS_FS=1.04;AS_MQ=60;AS_MQRankSum=0;AS_QD=3.28;AS_ReadPosRankSum=0.2;AS_SOR=0.861;BaseQRankSum=-1.09;DP=74;ExcessHet=3.0103;FS=1.04;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=3.28;ReadPosRankSum=0.265;SOR=0.861	GT:AD:DP:GQ:PL	0/1:56,18:74:99:250,0,1351
chr3	33058388	33058388	T	C	GLB1	intronic	.	.	.	1.0	GnomAdGenome_AF_ami	209.0	139.0	hom	123	3287.06	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	not_provided	criteria_provided,_single_submitter	Benign	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.9706	1.0	0.961661	0.0	0.0346934	0.973727	PASS	0.0	0.998	1.0	1.0	0.0	chr3	33058388	.	T	C	3287.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=26.72;AS_ReadPosRankSum=.;AS_SOR=0.709;DP=127;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=26.72;SOR=0.709	GT:AD:DP:GQ:PL	1/1:0,123:123:99:3301,367,0
chr3	33058632	33058632	A	G	GLB1	intronic	.	.	.	0.2636	GnomAdGenome_AF_eas	3.0	NA	het	158	657.64	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0626	0.2636	0.104034	0.0	0.0808744	0.0		0.0	0.049	4.0			chr3	33058632	.	A	G	657.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-1.2;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=4.16;AS_ReadPosRankSum=1.6;AS_SOR=0.672;BaseQRankSum=-1.114;DP=163;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=4.16;ReadPosRankSum=1.66;SOR=0.672	GT:AD:DP:GQ:PL	0/1:116,42:158:99:665,0,2770
chr3	33065969	33065969	A	-	GLB1	intronic	.	.	.	0.4069	GnomAdGenome_AF_sas	NA	NA	het	332	2443.02	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.3509	0.4069	0.391773	0.0	0.0003074	0.0		0.0					chr3	33065968	.	CA	C	2443.02	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=1.2;AS_FS=0.696;AS_MQ=57.67;AS_MQRankSum=-2;AS_QD=6.36;AS_ReadPosRankSum=1.6;AS_SOR=0.579;BaseQRankSum=0.576;DP=479;ExcessHet=3.0103;FS=2.994;MLEAC=1;MLEAF=0.5;MQ=58.75;MQRankSum=-1.666;QD=9.97;ReadPosRankSum=1.52;SOR=0.478	GT:AD:DP:GQ:PL	1/0:46,97:332:99:2460,601,1792
chr3	33065968	33065968	-	A	GLB1	intronic	.	.	.	0.3016	GnomAdGenome_AF_afr	NA	NA	het	332	2443.02	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0969	0.3016	0.0	0.0	0.0001153	0.0		0.0					chr3	33065968	.	C	CA	2443.02	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.9;AS_FS=7.101;AS_MQ=37.75;AS_MQRankSum=-1.9;AS_QD=3.99;AS_ReadPosRankSum=1.9;AS_SOR=0.714;BaseQRankSum=0.576;DP=479;ExcessHet=3.0103;FS=2.994;MLEAC=1;MLEAF=0.5;MQ=58.75;MQRankSum=-1.666;QD=9.97;ReadPosRankSum=1.52;SOR=0.478	GT:AD:DP:GQ:PL	0/1:46,102:332:99:2460,1755,3434
chr3	33066026	33066026	T	C	GLB1	intronic	.	.	.	0.316	GnomAdGenome_AF_eas	NA	NA	het	531	7258.64	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0955	0.316	0.147165	0.0	0.10919	0.0		0.0					chr3	33066026	.	T	C	7258.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.8;AS_FS=1.152;AS_MQ=60;AS_MQRankSum=0;AS_QD=13.67;AS_ReadPosRankSum=1.8;AS_SOR=0.58;BaseQRankSum=-0.75;DP=546;ExcessHet=3.0103;FS=1.152;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.67;ReadPosRankSum=1.81;SOR=0.58	GT:AD:DP:GQ:PL	0/1:220,311:531:99:7266,0,4805
chr3	33066153	33066153	C	T	GLB1	intronic	.	.	.	0.9456	GnomAdGenome_AF_ami	NA	NA	het	894	9408.64	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.7459	0.9456	0.651358	0.0	0.813893	0.0		0.0					chr3	33066153	.	C	T	9408.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=3;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=10.52;AS_ReadPosRankSum=-0.3;AS_SOR=0.679;BaseQRankSum=3.08;DP=924;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.52;ReadPosRankSum=-0.294;SOR=0.679	GT:AD:DP:GQ:PL	0/1:466,428:894:99:9416,0,10230
chr3	33066179	33066179	G	T	GLB1	intronic	.	.	.	0.415	GnomAdGenome_AF_afr	NA	NA	het	915	10570.6	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.1978	0.415	0.258387	0.0	0.143615	0.0		0.0					chr3	33066179	.	G	T	10570.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.4;AS_FS=0.521;AS_MQ=60;AS_MQRankSum=0;AS_QD=11.55;AS_ReadPosRankSum=0.3;AS_SOR=0.759;BaseQRankSum=-0.363;DP=942;ExcessHet=3.0103;FS=0.521;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.55;ReadPosRankSum=0.347;SOR=0.759	GT:AD:DP:GQ:PL	0/1:447,468:915:99:10578,0,10111
chr3	33066614	33066614	C	T	GLB1	intronic	.	.	.	1.0	GnomAdGenome_AF_ami	NA	NA	hom	847	24409.1	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.9821	1.0	0.972843	0.0	0.945904	0.0		0.0					chr3	33066614	.	C	T	24409.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=28.84;AS_ReadPosRankSum=.;AS_SOR=0.722;DP=880;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.85;SOR=0.724	GT:AD:DP:GQ:PL	1/1:0,846:847:99:24423,2531,0
chr3	33066749	33066749	C	A	GLB1	intronic	.	.	.	1.0	GnomAdGenome_AF_ami	NA	NA	hom	803	23482.1	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.954	1.0	0.921925	0.0	0.0001153	0.0		0.0					chr3	33066749	.	C	A	23482.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=29.24;AS_ReadPosRankSum=.;AS_SOR=0.757;DP=823;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.24;SOR=0.757	GT:AD:DP:GQ:PL	1/1:0,803:803:99:23496,2401,0
chr3	33067003	33067003	T	-	GLB1	intronic	.	.	.	0.0008	GnomAdGenome_AF_sas	NA	NA	het	316	1197.6	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0004	0.0008	0.0	0.0	0.0	0.0		0.0					chr3	33067002	.	CT	C	1197.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.6;AS_FS=5.318;AS_MQ=59.77;AS_MQRankSum=-0.4;AS_QD=1.99;AS_ReadPosRankSum=1.8;AS_SOR=1.087;BaseQRankSum=1.1;DP=451;ExcessHet=3.0103;FS=4.635;MLEAC=1;MLEAF=0.5;MQ=59.9;MQRankSum=-0.159;QD=6.3;ReadPosRankSum=0.778;SOR=0.967	GT:AD:DP:GQ:PL	0/1:117,73:316:99:1205,0,3036
chr3	33067063	33067063	C	T	GLB1	intronic	.	.	.	0.2568	GnomAdGenome_AF_eas	NA	NA	het	428	5611.64	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0601	0.2568	0.102037	0.0	0.0793376	0.0		0.0					chr3	33067063	.	C	T	5611.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=1.9;AS_FS=1.793;AS_MQ=59.98;AS_MQRankSum=-1.2;AS_QD=13.33;AS_ReadPosRankSum=2.5;AS_SOR=0.837;BaseQRankSum=1.42;DP=462;ExcessHet=3.0103;FS=0.536;MLEAC=1;MLEAF=0.5;MQ=59.96;MQRankSum=-1.118;QD=13.33;ReadPosRankSum=2.63;SOR=0.774	GT:AD:DP:GQ:PL	0/1:165,256:428:99:5619,0,2920
chr3	33067188	33067188	A	G	GLB1	intronic	.	.	.	0.9454	GnomAdGenome_AF_ami	NA	NA	het	662	5885.64	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.7482	0.9454	0.645367	0.0	0.0001537	0.0		0.0					chr3	33067188	.	A	G	5885.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.6;AS_FS=0.527;AS_MQ=59.64;AS_MQRankSum=-0.9;AS_QD=8.89;AS_ReadPosRankSum=-0.6;AS_SOR=0.71;BaseQRankSum=0.637;DP=687;ExcessHet=3.0103;FS=0.527;MLEAC=1;MLEAF=0.5;MQ=59.68;MQRankSum=-0.837;QD=8.89;ReadPosRankSum=-0.528;SOR=0.71	GT:AD:DP:GQ:PL	0/1:381,281:662:99:5893,0,8800
chr3	33067456	33067456	-	TTTTTAAAT	GLB1	intronic	.	.	.	1.0	GnomAdGenome_AF_ami	NA	NA	hom	741	34096.0	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.9578	1.0	0.925519	0.0	0.0003074	0.0		0.0					chr3	33067456	.	A	ATTTTTAAAT	34096.0	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=30.18;AS_ReadPosRankSum=.;AS_SOR=0.715;DP=844;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.46;SOR=0.707	GT:AD:DP:GQ:PL	1/1:0,738:741:99:34110,2297,0
chr3	33067596	33067596	C	T	GLB1	intronic	.	.	.	0.6949	GnomAdGenome_AF_ami	NA	NA	het	758	8137.64	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.479	0.6949	0.442093	0.0	0.562778	0.0		0.0					chr3	33067596	.	C	T	8137.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=3.3;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=10.74;AS_ReadPosRankSum=-1.6;AS_SOR=0.73;BaseQRankSum=3.31;DP=763;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.74;ReadPosRankSum=-1.545;SOR=0.73	GT:AD:DP:GQ:PL	0/1:394,364:758:99:8145,0,8327
chr3	33067995	33067995	T	C	GLB1	intronic	.	.	.	1.0	GnomAdGenome_AF_ami	77.0	NA	hom	704	20923.1	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	not_provided	criteria_provided,_single_submitter	Benign	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.9817	1.0	0.972843	0.0	0.946365	0.978541	PASS	0.0	0.053	0.0			chr3	33067995	.	T	C	20923.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=59.95;AS_MQRankSum=.;AS_QD=29.72;AS_ReadPosRankSum=.;AS_SOR=0.71;DP=723;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=59.91;QD=29.72;SOR=0.71	GT:AD:DP:GQ:PL	1/1:0,704:704:99:20937,2101,0
chr3	33068698	33068698	G	T	GLB1	intronic	.	.	.	0.6964	GnomAdGenome_AF_ami	72.0	23.0	het	815	8780.64	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	not_provided	criteria_provided,_single_submitter	Benign	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.4813	0.6964	0.444289	0.0	0.11137	0.565681	PASS	0.0	0.533	65.0	0.505814	41.0	chr3	33068698	.	G	T	8780.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=3;AS_FS=1.741;AS_MQ=60;AS_MQRankSum=0;AS_QD=10.77;AS_ReadPosRankSum=0.1;AS_SOR=0.731;BaseQRankSum=3.04;DP=828;ExcessHet=3.0103;FS=1.741;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.77;ReadPosRankSum=0.175;SOR=0.731	GT:AD:DP:GQ:PL	0/1:418,397:815:99:8788,0,9345
chr3	33069164	33069164	T	C	GLB1	intronic	.	.	.	1.0	GnomAdGenome_AF_ami	165.0	15.0	hom	766	19954.1	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	not_provided	criteria_provided,_single_submitter	Benign	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.9754	1.0	0.964058	0.0	0.942946	0.979475	PASS	0.0	0.012	0.0	1.0	0.0	chr3	33069164	.	T	C	19954.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=0.6;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=26.05;AS_ReadPosRankSum=-1.4;AS_SOR=0.346;BaseQRankSum=0.665;DP=799;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=26.05;ReadPosRankSum=-1.377;SOR=0.346	GT:AD:DP:GQ:PL	1/1:1,765:766:99:19968,2254,0
chr3	33069690	33069690	T	G	GLB1	intronic	.	.	.	0.4202	GnomAdGenome_AF_eas	NA	NA	het	847	9788.64	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.1489	0.4202	0.242212	0.0	0.14665	0.0		0.0					chr3	33069690	.	T	G	9788.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.9;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=11.56;AS_ReadPosRankSum=0.1;AS_SOR=0.734;BaseQRankSum=-0.865;DP=866;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.56;ReadPosRankSum=0.173;SOR=0.734	GT:AD:DP:GQ:PL	0/1:412,435:847:99:9796,0,9333
chr3	33069956	33069956	-	CCACCCTCCACCCT	GLB1	intronic	.	.	.	0.2623	GnomAdGenome_AF_eas	NA	NA	het	492	1219.6	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0785	0.2623	0.0	0.0	0.0102198	0.0		0.0					chr3	33069956	.	C	CCCACCCTCCACCCT	1219.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-1;AS_FS=99.224;AS_MQ=60;AS_MQRankSum=0;AS_QD=2.51;AS_ReadPosRankSum=3.6;AS_SOR=5.082;BaseQRankSum=-1.202;DP=665;ExcessHet=3.0103;FS=101.441;MLEAC=1;MLEAF=0.5;MQ=59.94;MQRankSum=0;QD=2.5;ReadPosRankSum=3.84;SOR=4.941	GT:AD:DP:GQ:PL	0/1:366,121:492:99:1227,0,14014
chr3	33072205	33072205	G	C	GLB1	intronic	.	.	.	0.3697	GnomAdGenome_AF_eas	5.0	NA	het	949	10494.6	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	.	.	.	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.1026	0.3697	0.161542	0.0	0.113532	0.0		0.0	0.07	2.0			chr3	33072205	.	G	C	10494.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-1.4;AS_FS=1.724;AS_MQ=60;AS_MQRankSum=0;AS_QD=11.06;AS_ReadPosRankSum=0.5;AS_SOR=0.844;BaseQRankSum=-1.334;DP=973;ExcessHet=3.0103;FS=1.724;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.06;ReadPosRankSum=0.51;SOR=0.844	GT:AD:DP:GQ:PL	0/1:479,470:949:99:10502,0,10908
chr3	33094100	33094100	T	C	TMPPE	exonic	synonymous SNV	.	TMPPE:NM_001039770:exon2:c.A96G:p.A32A	0.0711	GnomAdGenome_AF_ami	0.0	0.0	het	116	708.64	PASS	.	.	.	Likely benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	ovary;skin;blood;unclassifiable (Anatomical System);heart;	.	8.69E-02	.	N	N	N	0.282681495523763	N	Tmppe	.	.	.	.	.	0.0279	0.0411	0.0434	0.0276	0.0711	0.0147764	0.0268	0.0288483	0.018883	PASS	0.05	0.012	14.0	0.007042	2.0	chr3	33094100	.	T	C	708.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.8;AS_FS=2.546;AS_MQ=60;AS_MQRankSum=0;AS_QD=6.11;AS_ReadPosRankSum=-1;AS_SOR=0.875;BaseQRankSum=0.819;DP=120;ExcessHet=3.0103;FS=2.546;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=6.11;ReadPosRankSum=-0.933;SOR=0.875	GT:AD:DP:GQ:PL	0/1:78,38:116:99:716,0,1862
chr3	33094684	33094685	GG	-	GLB1;TMPPE	intronic	.	.	.	1.0	GnomAdGenome_AF_ami	NA	NA	hom	60	2610.03	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.0	0.0	0.0	0.9797	1.0	0.97524	0.0	0.0005379	0.0		0.0					chr3	33094683	.	AGG	A	2610.03	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=28.06;AS_ReadPosRankSum=.;AS_SOR=0.76;DP=69;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.2;SOR=0.76	GT:AD:DP:GQ:PL	1/1:0,60:60:99:2624,181,0
chr3	33095115	33095115	G	A	GLB1;TMPPE	intronic	.	.	.	0.0172	GnomAdGenome_AF_nfe	NA	NA	het	63	388.64	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.0	0.0	0.0	0.0103	0.0172	0.00579073	0.0	0.0126402	0.0		0.0					chr3	33095115	.	G	A	388.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.7;AS_FS=1.042;AS_MQ=60;AS_MQRankSum=0.7;AS_QD=6.17;AS_ReadPosRankSum=1.6;AS_SOR=0.859;BaseQRankSum=0.767;DP=64;ExcessHet=3.0103;FS=1.042;MLEAC=1;MLEAF=0.5;MQ=59.58;MQRankSum=0.716;QD=6.17;ReadPosRankSum=1.6;SOR=0.859	GT:AD:DP:GQ:PL	0/1:43,20:63:99:396,0,998
chr3	33095169	33095169	-	TCCTCTCAGACATT	GLB1;TMPPE	intronic	.	.	.	0.0	GnomAdExome_AF	NA	NA	het	37	224.6	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0					chr3	33095169	.	C	CTCCTCTCAGACATT	224.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.6;AS_FS=22.515;AS_MQ=60;AS_MQRankSum=0;AS_QD=6.08;AS_ReadPosRankSum=-1.4;AS_SOR=4.403;BaseQRankSum=0.654;DP=43;ExcessHet=3.0103;FS=22.515;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=6.07;ReadPosRankSum=-1.35;SOR=4.403	GT:AD:DP:GQ:PL	0/1:29,8:37:99:232,0,1150
chr3	33097008	33097008	-	A	TMPPE	UTR5	.	NM_001136238:c.-3225_-3224insT;NM_001039770:c.-2814_-2813insT	.	0.0021	GnomAdGenome_AF_fin	0.0	NA	het	69	507.6	PASS	.	.	.	.	.	.	.	.	.	Infantile_GM1_gangliosidosis|GM1_gangliosidosis_type_3|Mucopolysaccharidosis,_MPS-IV-B|GM1_gangliosidosis|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	Pathogenic	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	ovary;skin;blood;unclassifiable (Anatomical System);heart;	.	8.69E-02	.	N	N	N	0.282681495523763	N	Tmppe	.	.	.	.	.	0.0002	0.0002	0.0001	0.0002	0.0021	0.0	0.0	0.0001164	0.0		0.0	0.0006053	1.0			chr3	33097008	.	T	TA	507.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-1.7;AS_FS=3.787;AS_MQ=60;AS_MQRankSum=0;AS_QD=7.36;AS_ReadPosRankSum=-0.4;AS_SOR=1.257;BaseQRankSum=-1.637;DP=71;ExcessHet=3.0103;FS=3.787;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=7.36;ReadPosRankSum=-0.349;SOR=1.257	GT:AD:DP:GQ:PL	0/1:50,19:69:99:515,0,1643
chr3	33097052	33097052	A	G	GLB1	exonic	synonymous SNV	.	GLB1:NM_000404:exon1:c.T34C:p.L12L,GLB1:NM_001135602:exon1:c.T34C:p.L12L,GLB1:NM_001317040:exon1:c.T34C:p.L12L	0.9997	GnomAdExome_AF_eas	749.0	127.0	hom	64	2836.06	PASS	.	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	.	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	Infantile_GM1_gangliosidosis|GM1_gangliosidosis_type_2|GM1_gangliosidosis_type_3|Mucopolysaccharidosis,_MPS-IV-B|GM1_gangliosidosis|not_specified|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.9088	0.9997	0.9995	0.8857	0.9994	0.927716	0.8826	0.0001153	0.913793	PASS	0.973684	0.947	85.0	0.943662	14.0	chr3	33097052	.	A	G	2836.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=29.01;AS_ReadPosRankSum=.;AS_SOR=0.966;DP=65;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=33.03;SOR=0.966	GT:AD:DP:GQ:PGT:PID:PL:PS	1|1:0,64:64:99:1|1:33097052_A_G:2850,193,0:33097052
chr3	33097057	33097057	G	A	GLB1	exonic	nonsynonymous SNV	.	GLB1:NM_000404:exon1:c.C29T:p.P10L,GLB1:NM_001135602:exon1:c.C29T:p.P10L,GLB1:NM_001317040:exon1:c.C29T:p.P10L	0.698276	GME_SD	255.0	45.0	hom	65	2864.06	PASS	6.652	[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];	611458	Benign	Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];	HP:0001635;HP:0003510;HP:0000023;HP:0002808;HP:0001644;HP:0002007;HP:0000212;HP:0001522;HP:0004568;HP:0002240;HP:0010729;HP:0000007;HP:0001071;HP:0007313;HP:0001744;HP:0000457;HP:0001639;HP:0002650;HP:0001387;HP:0001654;HP:0008166;HP:0000316;HP:0000900;HP:0001249;HP:0001922;HP:0000079;HP:0000470;HP:0000998;HP:0000280;HP:0008479;HP:0002788;HP:0002240;HP:0003277;HP:0003621;HP:0000670;HP:0003016;HP:0003308;HP:0007759;HP:0000023;HP:0000926;HP:0000365;HP:0008166;HP:0000904;HP:0000683;HP:0001388;HP:0002091;HP:0002318;HP:0005292;HP:0003053;HP:0003049;HP:0012069;HP:0002808;HP:0003307;HP:0000280;HP:0001650;HP:0002650;HP:0003300;HP:0000939;HP:0000687;HP:0000884;HP:0000303;HP:0002857;HP:0000007;HP:0003521;HP:0001223;HP:0002673;HP:0003311;HP:0000154;HP:0001350;HP:0004322;HP:0003274;HP:0008430;HP:0000926;HP:0001256;HP:0003651;HP:0003202;HP:0002869;HP:0002808;HP:0007759;HP:0000271;HP:0008166;HP:0002506;HP:0002650;HP:0001871;HP:0000007;HP:0001332;HP:0001982;HP:0001251;HP:0002119;HP:0000271;HP:0000648;HP:0008166;HP:0002059;HP:0002123;HP:0002510;HP:0002673;HP:0008166;HP:0007272;HP:0001392;HP:0000007;HP:0001288;HP:0001743;HP:0000926;HP:0007281;HP:0007281	Congestive heart failure;Severe short stature;Inguinal hernia;Kyphosis;Dilated cardiomyopathy;Frontal bossing;Gingival overgrowth;Death in infancy;Beaking of vertebral bodies;Hepatomegaly;Cherry red spot of the macula;Autosomal recessive inheritance;Angiokeratoma corporis diffusum;Cerebral degeneration;Splenomegaly;Depressed nasal ridge;Hypertrophic cardiomyopathy;Scoliosis;Joint stiffness;Abnormal heart valve morphology;Decreased beta-galactosidase activity;Hypertelorism;Thickened ribs;Intellectual disability;Vacuolated lymphocytes;Abnormality of the urinary system;Short neck;Hypertrichosis;Coarse facial features;Hypoplastic vertebral bodies;Recurrent upper respiratory tract infections;Hepatomegaly;Constricted iliac wings;Juvenile onset;Carious teeth;Metaphyseal widening;Cervical subluxation;Opacification of the corneal stroma;Inguinal hernia;Platyspondyly;Hearing impairment;Decreased beta-galactosidase activity;Flaring of rib cage;Grayish enamel;Joint laxity;Restrictive ventilatory defect;Cervical myelopathy;Intimal thickening in the coronary arteries;Epiphyseal deformities of tubular bones;Ulnar deviation of the wrist;Keratan sulfate excretion in urine;Kyphosis;Hyperlordosis;Coarse facial features;Aortic valve stenosis;Scoliosis;Ovoid vertebral bodies;Osteoporosis;Widely spaced teeth;Prominent sternum;Mandibular prognathia;Genu valgum;Autosomal recessive inheritance;Disproportionate short-trunk short stature;Pointed proximal second through fifth metacarpals;Coxa valga;Hypoplasia of the odontoid process;Wide mouth;Slurred speech;Short stature;Hypoplastic acetabulae;Anterior beaking of lumbar vertebrae;Platyspondyly;Intellectual disability, mild;Foam cells;Skeletal muscle atrophy;Flared iliac wings;Kyphosis;Opacification of the corneal stroma;Abnormality of the face;Decreased beta-galactosidase activity;Diffuse cerebral atrophy;Scoliosis;Abnormality of blood and blood-forming tissues;Autosomal recessive inheritance;Dystonia;Sea-blue histiocytosis;Ataxia;Ventriculomegaly;Abnormality of the face;Optic atrophy;Decreased beta-galactosidase activity;Cerebral atrophy;Generalized myoclonic seizure;Spastic tetraplegia;Coxa valga;Decreased beta-galactosidase activity;Progressive psychomotor deterioration;Abnormality of the liver;Autosomal recessive inheritance;Gait disturbance;Abnormality of the spleen;Platyspondyly;Developmental stagnation;Developmental stagnation	Infantile_GM1_gangliosidosis|GM1_gangliosidosis_type_2|GM1_gangliosidosis_type_3|Mucopolysaccharidosis,_MPS-IV-B|GM1_gangliosidosis|not_specified|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Detected in placenta (at protein level) (PubMed:8383699). Detected in fibroblasts and testis (PubMed:2511208). {ECO:0000269|PubMed:2511208, ECO:0000269|PubMed:8383699}.;	T	T	B	B	N	P	.	D	N	T	T	T	.	T	T	T	T	T	.;.;.;.;	N	N	.;.;.;.	.	.	Medium	Medium	Medium	stomach;testis;choroid;kidney;uterus;whole body;pancreas;bile duct;skeletal muscle;mesenchyma;islets of Langerhans;visual apparatus;fovea centralis;spleen;liver;germinal center;heart;lung;thyroid;sympathetic chain;placenta;nasopharynx;optic nerve;tongue;smooth muscle;skin;pituitary gland;lens;unclassifiable (Anatomical System);retina;head and neck;mammary gland;spinal cord;cervix;hippocampus;cartilage;endometrium;bone;parathyroid;brain;bone marrow;ovary;macula lutea;lymph node;colon;aorta;prostate;breast;hypothalamus;medulla oblongata;	superior cervical ganglion;	4.64E-02	N	N	N	N	0.939438274154661	E	Glb1	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 	.	.	.	.	0.5674	0.6218	0.6183	0.4739	0.6933	0.431909	0.474	0.0001153	0.568966	PASS	0.698276	0.539	392.0	0.556338	68.0	chr3	33097057	.	G	A	2864.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=33.1;AS_ReadPosRankSum=.;AS_SOR=0.925;DP=65;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=26.74;SOR=0.925	GT:AD:DP:GQ:PGT:PID:PL:PS	1|1:0,65:65:99:1|1:33097052_A_G:2878,196,0:33097052
chr3	33097271	33097271	C	A	GLB1;TMPPE	upstream	.	dist=41	.	0.6948	GnomAdGenome_AF_ami	65.0	NA	hom	59	2532.06	PASS	.	.	.	.	.	.	.	.	.	not_provided	criteria_provided,_single_submitter	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.0	0.0	0.0	0.4733	0.6948	0.432708	0.0	0.382588	0.315353	VQSRTrancheSNP99.00to99.90	0.0	0.556	67.0			chr3	33097271	.	C	A	2532.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=31.94;AS_ReadPosRankSum=.;AS_SOR=0.871;DP=60;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34.6;SOR=0.871	GT:AD:DP:GQ:PGT:PID:PL:PS	1|1:0,59:59:99:1|1:33097271_C_A:2546,178,0:33097271
chr3	33097272	33097272	G	C	GLB1;TMPPE	upstream	.	dist=42	.	0.6948	GnomAdGenome_AF_ami	65.0	NA	hom	59	2532.06	PASS	.	.	.	.	.	.	.	.	.	not_provided	criteria_provided,_single_submitter	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.0	0.0	0.0	0.4733	0.6948	0.432708	0.0	0.405755	0.347107	PASS	0.0	0.556	67.0			chr3	33097272	.	G	C	2532.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=30.15;AS_ReadPosRankSum=.;AS_SOR=0.871;DP=60;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=26.67;SOR=0.871	GT:AD:DP:GQ:PGT:PID:PL:PS	1|1:0,59:59:99:1|1:33097271_C_A:2546,178,0:33097271
chr3	33097518	33097518	T	-	GLB1;TMPPE	upstream	.	dist=288	.	0.6946	GnomAdGenome_AF_ami	NA	NA	hom	52	2061.03	PASS	.	.	.	.	.	.	.	.	.	not_provided	criteria_provided,_single_submitter	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.0	0.0	0.0	0.4888	0.6946	0.447484	0.0	0.101967	0.0		0.0					chr3	33097517	.	CT	C	2061.03	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=31.08;AS_ReadPosRankSum=.;AS_SOR=1.036;DP=54;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=35.86;SOR=1.036	GT:AD:DP:GQ:PL	1/1:0,52:52:99:2075,157,0
chr12	101757571	101757571	C	T	GNPTAB	splicing	.	NM_024312:exon17:c.3335+1G>A	.	0.000399361	1000g2015aug_all	NA	NA	hom	563	16449.1	PASS	33	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	Mucolipidosis_type_II|Pseudo-Hurler_polydystrophy|Mucolipidosis|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	Pathogenic	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	A	.	.	.	.	.	.	.	.	.	D	.	.	.;	D	.	.	1.0000	0.938	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	3.185e-05	0.0003	0.0003	0.0	0.0	0.000399361	0.0	5.17e-05	0.0		0.0					chr12	101757571	.	C	T	16449.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=29.22;AS_ReadPosRankSum=.;AS_SOR=0.74;DP=579;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.22;SOR=0.74	GT:AD:DP:GQ:PL	1/1:0,563:563:99:16463,1681,0
chr12	101758038	101758038	T	-	GNPTAB	intronic	.	.	.	0.4808	GnomAdGenome_AF_afr	NA	NA	het	136	352.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.2877	0.4808	0.317692	0.0	0.0004995	0.0		0.0					chr12	101758037	.	AT	A	352.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.5;AS_FS=0.793;AS_MQ=58.79;AS_MQRankSum=-2.4;AS_QD=3.3;AS_ReadPosRankSum=0.9;AS_SOR=0.568;BaseQRankSum=-0.338;DP=253;ExcessHet=3.0103;FS=0.637;MLEAC=1;MLEAF=0.5;MQ=59.19;MQRankSum=-2.278;QD=3.64;ReadPosRankSum=0.625;SOR=0.614	GT:AD:DP:GQ:PL	0/1:62,35:136:99:360,0,1454
chr12	101759420	101759420	A	-	GNPTAB	intronic	.	.	.	0.0223	GnomAdGenome_AF_afr	NA	NA	het	185	1029.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0131	0.0223	0.0	0.0	9.06e-05	0.0		0.0					chr12	101759419	.	TA	T	1029.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.9;AS_FS=1.521;AS_MQ=60;AS_MQRankSum=0;AS_QD=5.75;AS_ReadPosRankSum=0.4;AS_SOR=0.521;BaseQRankSum=1.28;DP=204;ExcessHet=3.0103;FS=1.306;MLEAC=1;MLEAF=0.5;MQ=59.96;MQRankSum=0;QD=6.73;ReadPosRankSum=0.272;SOR=0.545	GT:AD:DP:GQ:PL	0/1:98,55:185:99:1037,0,2235
chr12	101760782	101760782	T	-	GNPTAB	intronic	.	.	.	0.0074	GnomAdGenome_AF_fin	NA	NA	het	282	1466.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0014	0.0074	0.0	0.0	0.0001537	0.0		0.0					chr12	101760781	.	CT	C	1466.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0;AS_FS=15.459;AS_MQ=58.14;AS_MQRankSum=0;AS_QD=2.1;AS_ReadPosRankSum=-0.5;AS_SOR=1.523;BaseQRankSum=0.621;DP=343;ExcessHet=3.0103;FS=10.823;MLEAC=1;MLEAF=0.5;MQ=59.73;MQRankSum=-1.094;QD=7.05;ReadPosRankSum=0.393;SOR=1.149	GT:AD:DP:GQ:PL	0/1:126,82:282:99:1474,0,2140
chr12	101762904	101762905	AA	-	GNPTAB	intronic	.	.	.	0.002	GnomAdGenome_AF_eas	NA	NA	het	144	1048.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0002	0.002	0.0	0.0	0.0	0.0		0.0					chr12	101762903	.	TAA	T	1048.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.8;AS_FS=1.992;AS_MQ=59.58;AS_MQRankSum=-1.1;AS_QD=2.47;AS_ReadPosRankSum=-0.3;AS_SOR=0.465;BaseQRankSum=1.61;DP=266;ExcessHet=3.0103;FS=2.423;MLEAC=1;MLEAF=0.5;MQ=59.84;MQRankSum=-0.858;QD=14.56;ReadPosRankSum=0.503;SOR=0.507	GT:AD:DP:GQ:PL	0/1:39,33:144:99:1056,0,1437
chr12	101763222	101763222	A	-	GNPTAB	intronic	.	.	.	0.0168	GnomAdGenome_AF_afr	NA	NA	het	227	1361.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0074	0.0168	0.0	0.0	0.000461	0.0		0.0					chr12	101763221	.	CA	C	1361.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.4;AS_FS=0.604;AS_MQ=60;AS_MQRankSum=0;AS_QD=2.95;AS_ReadPosRankSum=2.3;AS_SOR=0.801;BaseQRankSum=0.183;DP=279;ExcessHet=3.0103;FS=0.508;MLEAC=1;MLEAF=0.5;MQ=59.92;MQRankSum=0;QD=8.06;ReadPosRankSum=2.33;SOR=0.737	GT:AD:DP:GQ:PL	0/1:103,66:227:99:1369,0,1993
chr12	101763451	101763451	T	-	GNPTAB	intronic	.	.	.	0.003	GnomAdGenome_AF_afr	NA	NA	het	345	962.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0012	0.003	0.0	0.0	8.41e-05	0.0		0.0					chr12	101763450	.	AT	A	962.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-1.1;AS_FS=0.494;AS_MQ=60;AS_MQRankSum=0;AS_QD=3.12;AS_ReadPosRankSum=0.7;AS_SOR=0.742;BaseQRankSum=-0.807;DP=400;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=3.12;ReadPosRankSum=0.499;SOR=0.685	GT:AD:DP:GQ:PL	0/1:239,70:345:99:970,0,6072
chr12	101768901	101768901	-	GCTCTTCCCTCTCCCT	GNPTAB	intronic	.	.	.	0.0	GnomAdExome_AF	NA	NA	het	555	2309.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0					chr12	101768901	.	A	AGCTCTTCCCTCTCCCT	2309.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=1;AS_FS=84.785;AS_MQ=60;AS_MQRankSum=0;AS_QD=4.18;AS_ReadPosRankSum=-9.4;AS_SOR=9.022;BaseQRankSum=0.709;DP=604;ExcessHet=3.0103;FS=87.74;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=4.18;ReadPosRankSum=-9.486;SOR=9.065	GT:AD:DP:GQ:PL	0/1:463,90:555:99:2317,0,18862
chr12	101771247	101771247	T	-	GNPTAB	intronic	.	.	.	0.295983	abraom_freq	3.0	1.0	het	172	1042.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	not_provided	criteria_provided,_single_submitter	Likely_benign	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0143	0.0399	0.0	0.0	0.0001921	0.295983	PASS	0.0	0.065	11.0	0.127907	31.0	chr12	101771246	.	CT	C	1042.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.3;AS_FS=4.651;AS_MQ=60;AS_MQRankSum=0;AS_QD=1.36;AS_ReadPosRankSum=-0.2;AS_SOR=0.862;BaseQRankSum=-0.379;DP=247;ExcessHet=3.0103;FS=1.213;MLEAC=1;MLEAF=0.5;MQ=59.9;MQRankSum=0;QD=8.99;ReadPosRankSum=-0.033;SOR=0.573	GT:AD:DP:GQ:PL	0/1:70,46:172:99:1050,0,1502
chr12	101778905	101778905	A	-	GNPTAB	intronic	.	.	.	0.0016	GnomAdGenome_AF_fin	NA	NA	het	257	963.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0004	0.0016	0.0	0.0	0.0002305	0.0		0.0					chr12	101778904	.	CA	C	963.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=1.4;AS_FS=3.455;AS_MQ=60;AS_MQRankSum=0;AS_QD=3.96;AS_ReadPosRankSum=0.6;AS_SOR=0.981;BaseQRankSum=1.37;DP=294;ExcessHet=3.0103;FS=2.848;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=4.32;ReadPosRankSum=0.809;SOR=0.88	GT:AD:DP:GQ:PL	0/1:162,61:257:99:971,0,4095
chr12	101787913	101787913	-	A	GNPTAB	intronic	.	.	.	0.8168	GnomAdGenome_AF_amr	NA	NA	het	194	677.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.7061	0.8168	0.701877	0.0	0.0004226	0.0		0.0					chr12	101787913	.	C	CA	677.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-1.2;AS_FS=0;AS_MQ=48.81;AS_MQRankSum=0.9;AS_QD=1.74;AS_ReadPosRankSum=-0.9;AS_SOR=0.648;BaseQRankSum=-0.651;DP=373;ExcessHet=3.0103;FS=1.407;MLEAC=1;MLEAF=0.5;MQ=59.13;MQRankSum=0.038;QD=5.38;ReadPosRankSum=0.74;SOR=0.554	GT:AD:DP:GQ:PL	0/1:58,68:194:99:685,0,1536
chr12	101790293	101790293	C	T	GNPTAB	intronic	.	.	.	0.9994	GnomAdGenome_AF_eas	113.0	NA	hom	597	16900.1	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	not_provided	criteria_provided,_single_submitter	Benign	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.9716	0.9994	0.982428	0.0	0.161395	0.978261	PASS	0.0	0.942	2.0			chr12	101790293	.	C	T	16900.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=1;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=28.31;AS_ReadPosRankSum=0.8;AS_SOR=0.887;BaseQRankSum=1.01;DP=604;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=28.31;ReadPosRankSum=0.873;SOR=0.887	GT:AD:DP:GQ:PL	1/1:2,595:597:99:16914,1736,0
chr12	101796906	101796906	-	TGTGACTGGCCG	GNPTAB	intronic	.	.	.	0.0	GnomAdExome_AF	NA	NA	het	1336	6174.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0					chr12	101796906	.	A	ATGTGACTGGCCG	6174.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=4.3;AS_FS=88.047;AS_MQ=60;AS_MQRankSum=0;AS_QD=4.62;AS_ReadPosRankSum=22.1;AS_SOR=10.837;BaseQRankSum=4.33;DP=1398;ExcessHet=3.0103;FS=88.047;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=4.62;ReadPosRankSum=22.19;SOR=10.837	GT:AD:DP:GQ:PGT:PID:PL:PS	0|1:1053,283:1336:99:0|1:101796906_A_ATGTGACTGGCCG:6182,0,24271:101796906
chr16	88816004	88816004	A	G	GALNS	intronic	.	.	.	0.1428	GnomAdGenome_AF_afr	NA	NA	hom	155	4405.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	8.38E-02	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.1283	0.1428	0.0884585	0.0	0.117604	0.0		0.0					chr16	88816004	.	A	G	4405.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=28.42;AS_ReadPosRankSum=.;AS_SOR=0.786;DP=158;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.42;SOR=0.786	GT:AD:DP:GQ:PL	1/1:0,155:155:99:4419,462,0
chr16	88825741	88825741	G	T	GALNS	intronic	.	.	.	0.0	GnomAdExome_AF	NA	NA	het	403	895.64	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	8.38E-02	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0					chr16	88825741	.	G	T	895.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.8;AS_FS=16.913;AS_MQ=59.5;AS_MQRankSum=-3.6;AS_QD=2.22;AS_ReadPosRankSum=-5.5;AS_SOR=2.004;BaseQRankSum=-0.744;DP=407;ExcessHet=3.0103;FS=16.913;MLEAC=1;MLEAF=0.5;MQ=59.93;MQRankSum=-3.557;QD=2.22;ReadPosRankSum=-5.455;SOR=2.004	GT:AD:DP:GQ:PGT:PID:PL:PS	0|1:348,55:403:99:0|1:88825741_G_T:903,0,14085:88825741
chr16	88825746	88825746	-	TCCTCCCTGTCTTA	GALNS	intronic	.	.	.	0.0	GnomAdExome_AF	NA	NA	het	402	897.6	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	8.38E-02	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0					chr16	88825746	.	C	CTCCTCCCTGTCTTA	897.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.3;AS_FS=16.993;AS_MQ=59.5;AS_MQRankSum=-3.6;AS_QD=2.23;AS_ReadPosRankSum=-7.4;AS_SOR=2.003;BaseQRankSum=0.32;DP=405;ExcessHet=3.0103;FS=16.993;MLEAC=1;MLEAF=0.5;MQ=59.93;MQRankSum=-3.552;QD=2.23;ReadPosRankSum=-7.349;SOR=2.003	GT:AD:DP:GQ:PGT:PID:PL:PS	0|1:347,55:402:99:0|1:88825741_G_T:905,0,14212:88825741
chr16	88828798	88828798	C	T	GALNS	intronic	.	.	.	0.5851	GnomAdGenome_AF_nfe	NA	NA	hom	381	10511.1	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	8.38E-02	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.5043	0.5851	0.446286	0.0	0.0189796	0.0		0.0					chr16	88828798	.	C	T	10511.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=27.59;AS_ReadPosRankSum=.;AS_SOR=0.821;DP=403;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.59;SOR=0.821	GT:AD:DP:GQ:PL	1/1:0,381:381:99:10525,1130,0
chr16	88833078	88833079	AA	-	GALNS	intronic	.	.	.	0.4576	GnomAdGenome_AF_eas	NA	NA	het	122	499.6	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	8.38E-02	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.2597	0.4576	0.0	0.0	0.0001153	0.0		0.0					chr16	88833077	.	CAA	C	499.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.9;AS_FS=4.562;AS_MQ=57.71;AS_MQRankSum=1.7;AS_QD=0.87;AS_ReadPosRankSum=-0.4;AS_SOR=0.221;BaseQRankSum=-1.325;DP=205;ExcessHet=3.0103;FS=8.03;MLEAC=1;MLEAF=0.5;MQ=58;MQRankSum=2.1;QD=5.88;ReadPosRankSum=-0.134;SOR=0.207	GT:AD:DP:GQ:PL	0/1:64,21:122:99:507,0,1709
chr16	88833455	88833456	TT	-	GALNS	intronic	.	.	.	0.0006	GnomAdGenome_AF_asj	NA	NA	het	187	1161.6	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	8.38E-02	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0001	0.0006	0.0	0.0	0.0002689	0.0		0.0					chr16	88833454	.	CTT	C	1161.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=1.2;AS_FS=5.34;AS_MQ=60;AS_MQRankSum=1.3;AS_QD=0.63;AS_ReadPosRankSum=1.5;AS_SOR=0.33;BaseQRankSum=1.13;DP=247;ExcessHet=3.0103;FS=10.703;MLEAC=1;MLEAF=0.5;MQ=59.14;MQRankSum=-0.275;QD=11.5;ReadPosRankSum=1.23;SOR=0.275	GT:AD:DP:GQ:PL	0/1:63,38:187:99:1169,0,2698
chr16	88835979	88835979	A	G	GALNS	intronic	.	.	.	0.2127	GnomAdGenome_AF_sas	6.0	2.0	hom	263	6881.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	not_provided	criteria_provided,_single_submitter	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	8.38E-02	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.1349	0.2127	0.111022	0.0	0.0199609	0.149416	PASS	0.0	0.158	45.0	0.114286	12.0	chr16	88835979	.	A	G	6881.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=1.6;AS_FS=0;AS_MQ=58.84;AS_MQRankSum=-0.4;AS_QD=26.16;AS_ReadPosRankSum=0;AS_SOR=0.299;BaseQRankSum=1.61;DP=282;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=58.89;MQRankSum=-0.318;QD=26.16;ReadPosRankSum=0.033;SOR=0.299	GT:AD:DP:GQ:PL	1/1:1,262:263:99:6895,772,0
chr16	88836657	88836657	A	-	GALNS	intronic	.	.	.	0.007	GnomAdGenome_AF_fin	NA	NA	het	220	888.6	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	8.38E-02	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0013	0.007	0.0	0.0	0.0003458	0.0		0.0					chr16	88836656	.	GA	G	888.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.5;AS_FS=2.197;AS_MQ=60;AS_MQRankSum=0;AS_QD=3.55;AS_ReadPosRankSum=-1.1;AS_SOR=0.741;BaseQRankSum=-1.206;DP=274;ExcessHet=3.0103;FS=2.344;MLEAC=1;MLEAF=0.5;MQ=59.93;MQRankSum=0;QD=6.21;ReadPosRankSum=-0.769;SOR=0.873	GT:AD:DP:GQ:PL	0/1:92,51:220:99:896,0,2569
chr16	88841898	88841898	G	C	GALNS	exonic	nonsynonymous SNV	.	GALNS:NM_000512:exon3:c.C318G:p.N106K,GALNS:NM_001323544:exon4:c.C336G:p.N112K	0.0	GnomAdExome_AF	NA	NA	hom	158	4445.06	PASS	18.57	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	Uncertain significance	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	T	T	D	D	D	D	L	D	N	T	T	D	D	T	D	T	D	D	.;.;	N	N	Sulfatase, N-terminal;Sulfatase, N-terminal	0.0033	0.22	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	8.38E-02	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0					chr16	88841898	.	G	C	4445.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=28.13;AS_ReadPosRankSum=.;AS_SOR=0.798;DP=162;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.13;SOR=0.798	GT:AD:DP:GQ:PL	1/1:0,158:158:99:4459,469,0
chr16	88853252	88853254	AAA	-	GALNS	intronic	.	.	.	0.0706	GnomAdGenome_AF_nfe	NA	NA	het	13	199.61	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	8.38E-02	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0462	0.0706	0.0	0.0	0.0001153	0.0		0.0					chr16	88853251	.	CAAA	C	199.61	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0;AS_FS=0;AS_MQ=57.15;AS_MQRankSum=-0.2;AS_QD=18.14;AS_ReadPosRankSum=0;AS_SOR=0.527;BaseQRankSum=0.674;DP=38;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=59.19;MQRankSum=0;QD=28.52;ReadPosRankSum=0;SOR=0.941	GT:AD:DP:GQ:PL	0/1:1,6:13:99:207,0,311
